KBC Securities advice for Bone Therapeutics
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| February 21, 2018 | KBC Securities | Bone Therapeutics | Buy | 11.00 EUR | 68.18 % |
Advice details
Brussels - Op 21 feb herhalen de analisten van KBC Securities hun koopadvies voor Bone Therapeutics (ISIN: BE0974280126). Het 12-maands koersdoel blijft gehandhaafd op 11.0 EUR.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 